Vanguard® crLyme helps provide broad spectrum coverage against outer
surface protein A (OspA), found in the tick, and contains antigens from
multiple types of outer surface protein C (OspC), found in the tick and
dog. Indication: For vaccination of healthy dogs 8 weeks of age or older
as an aid in prevention of clinical disease and subclinical arthritis
associated with Borrelia burgdorferi. Key Benefits: The first Lyme
disease vaccine for dogs to contain a recombinant OspC protein.
Demonstrated efficacy in helping prevent Lyme infection. Excellent
performance in a field safety study. Thimerosal free. Covered by
Companion Animal Immunization Support Guarantee (ISG).
surface protein A (OspA), found in the tick, and contains antigens from
multiple types of outer surface protein C (OspC), found in the tick and
dog. Indication: For vaccination of healthy dogs 8 weeks of age or older
as an aid in prevention of clinical disease and subclinical arthritis
associated with Borrelia burgdorferi. Key Benefits: The first Lyme
disease vaccine for dogs to contain a recombinant OspC protein.
Demonstrated efficacy in helping prevent Lyme infection. Excellent
performance in a field safety study. Thimerosal free. Covered by
Companion Animal Immunization Support Guarantee (ISG).
- (Loading SDS PDF) SDS Sheet